Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer

Journal of Gastroenterology and Hepatology (Australia)

Volumn 18, Issue 9, 2003, Pages 1095-1100

  Gibson, Rachel J ^a,c   Bowen, Joanne M ^a,c   Inglis, Mark R B ^a   Cummins, Adrian G ^b,c   Keefe, Dorothy M K ^a,c  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Apoptosis; Irinotecan; Mucositis; Small intestine

Indexed keywords

IRINOTECAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CHRONOSEQUENCE; COLON INJURY; COLON MUCOSA; CONTROLLED STUDY; DATA ANALYSIS; DIARRHEA; DISEASE SIMULATION; DRUG EFFECT; EXPERIMENTAL MODEL; GOBLET CELL; HISTOPATHOLOGY; HYPOPLASIA; INTESTINE CRYPT; INTESTINE INJURY; INTESTINE VILLUS ATROPHY; LARGE INTESTINE; MORPHOMETRICS; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE SECTION;

EID: 0141618280     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2003.03136.x     Document Type: Article

References (10)

1. Araki E, Ishikawa M, Iigo M, Koide T, Itabashi M, Hoshi A. Relationship between development of diarrhea and the concentration of SN-38, an active metabolite of CPT-11, in the intestine and the blood plasma of athymic mice following intraperitoneal administration of CPT-11;. Jpn J. Cancer Res. 1993; 84: 697-702.
2. Cao S, Black JD, Troutt AB, Rustum YM. Interleukin 15 offers selective protection from irinotecan-induced intestinal toxicity in a preclinical animal model. Cancer Res. 1998; 58: 3270-4.
3. Ikuno N, Soda H, Watanabe M, Oka M. Irinotecan (CPT-11) and characteristic changes in the mouse ileum and cecum. J. Natl. Cancer Inst. 1995; 87: 1876-83.
4. Takasuna KTH, Hirohashi M, Kato M et al. Involvement of β-Glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats. Cancer Res. 1996; 56: 3752-7.
5. Gibson RJ, Keefe DMK, Thompson FM, Clarke JM, Goland GJ, Cummins AG. Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats. Dig. Dis. Sci. 2002; 47: 2751-7.
6. Gibson RJ, Keefe DMK, Clarke JM et al. The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer. Cancer Chem. Pharm. 2002; 50: 53-8.
7. Keefe DM, Brealey J, Goland GJ, Cummins AG. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 2000; 47: 632-7.
8. Masuda N, Fukuoka M, Kudoh S et al. Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small cell lung cancer. J. Clin. Oncol. 1994; 12: 90-6.
9. Cummins AG, LaBrooy JT, Stanley DP, Rowland R, Shearman DJC. A quantitative histological study of enteropathy associated with HIV infection. Gut 1990; 31: 317-21.
10. Harper JF. Peritz' F-test: basic programme of a robust multiple comparison test for statistical analysis of all differences among group means. Comput. Biol. Med. 1994; 14: 437-45.